These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34627195)

  • 1. Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection.
    Hedetoft M; Hansen MB; Madsen MB; Johansen JS; Hyldegaard O
    BMC Infect Dis; 2021 Oct; 21(1):1046. PubMed ID: 34627195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Necrotising Soft Tissue Infections Aspects of the Innate Immune Response.
    Hansen MB
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
    Hansen MB; Rasmussen LS; Garred P; Bidstrup D; Madsen MB; Hyldegaard O
    Crit Care; 2016 Feb; 20():40. PubMed ID: 26880104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
    Hansen MB; Rasmussen LS; Garred P; Pilely K; Wahl AM; Perner A; Madsen MB; Hedegaard ER; Simonsen U; Hyldegaard O
    Shock; 2018 Jun; 49(6):667-674. PubMed ID: 28863028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble ICAM-1 is modulated by hyperbaric oxygen treatment and correlates with disease severity and mortality in patients with necrotizing soft-tissue infection.
    Hedetoft M; Moser C; Jensen PØ; Vinkel J; Hyldegaard O
    J Appl Physiol (1985); 2021 Mar; 130(3):729-736. PubMed ID: 33444122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study.
    Polzik P; Grøndal O; Tavenier J; Madsen MB; Andersen O; Hedetoft M; Hyldegaard O
    Sci Rep; 2019 Mar; 9(1):5098. PubMed ID: 30911053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection.
    Hedetoft M; Madsen MB; Hansen CB; Hyldegaard O; Garred P
    J Innate Immun; 2022; 14(4):355-365. PubMed ID: 34903692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: a multicentre, prospective study.
    Hansen MB; Rasmussen LS; Svensson M; Chakrakodi B; Bruun T; Madsen MB; Perner A; Garred P; Hyldegaard O; Norrby-Teglund A;
    Sci Rep; 2017 Feb; 7():42179. PubMed ID: 28176831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection.
    Hedetoft M; Garred P; Madsen MB; Hyldegaard O
    Physiol Rep; 2021 Mar; 9(6):e14757. PubMed ID: 33719215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperbaric oxygen treatment impacts oxidative stress markers in patients with necrotizing soft-tissue infection.
    Hedetoft M; Jensen PØ; Moser C; Vinkel J; Hyldegaard O
    J Investig Med; 2021 Oct; 69(7):1330-1338. PubMed ID: 34006573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.
    Hua C; Sbidian E; Hemery F; Decousser JW; Bosc R; Amathieu R; Rahmouni A; Wolkenstein P; Valeyrie-Allanore L; Brun-Buisson C; de Prost N; Chosidow O
    J Am Acad Dermatol; 2015 Dec; 73(6):1006-12.e8. PubMed ID: 26412163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study.
    Madsen MB; Skrede S; Perner A; Arnell P; Nekludov M; Bruun T; Karlsson Y; Hansen MB; Polzik P; Hedetoft M; Rosén A; Saccenti E; Bergey F; Martins Dos Santos VAP; ; Norrby-Teglund A; Hyldegaard O
    Intensive Care Med; 2019 Sep; 45(9):1241-1251. PubMed ID: 31440795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study.
    Bruun T; Rath E; Madsen MB; Oppegaard O; Nekludov M; Arnell P; Karlsson Y; Babbar A; Bergey F; Itzek A; Hyldegaard O; Norrby-Teglund A; Skrede S;
    Clin Infect Dis; 2021 Jan; 72(2):293-300. PubMed ID: 31923305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.
    Holmgaard DB; Mygind LH; Titlestad IL; Madsen H; Pedersen SS; Johansen JS; Pedersen C
    BMC Pulm Med; 2013 Dec; 13():77. PubMed ID: 24373580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminatory plasma biomarkers predict specific clinical phenotypes of necrotizing soft-tissue infections.
    Palma Medina LM; Rath E; Jahagirdar S; Bruun T; Madsen MB; Strålin K; Unge C; Hansen MB; Arnell P; Nekludov M; Hyldegaard O; Lourda M; Santos VAMD; Saccenti E; Skrede S; Svensson M; Norrby-Teglund A
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34263738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
    Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P
    Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher LRINEC Scores and Escalation of Anesthesia Care in Necrotizing Soft Tissue Infection.
    Tessler RA; Vanhoy S; Bergus K; Fong C; Bulger EM; Rivara FP; Vavilala MS
    J Surg Res; 2019 Jun; 238():119-126. PubMed ID: 30769248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis.
    Arain F; Abraityte A; Bogdanova M; Solberg OG; Michelsen AE; Lekva T; Aakhus S; Holm S; Halvorsen B; Finsen AV; Vinge LE; Nymo S; Espeland T; Ranheim T; Aukrust P; Vaage IJ; Auensen A; Gullestad L; Ueland T
    Circ Heart Fail; 2020 Oct; 13(10):e006643. PubMed ID: 32962417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing Outcomes Among Older Adults With Necrotizing Soft-Tissue Infections in the United States.
    McCarty AR; Villarreal ME; Tamer R; Strassels SA; Schubauer KM; Paredes AZ; Santry H; Wisler JR
    J Surg Res; 2021 Jan; 257():107-117. PubMed ID: 32818779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection.
    Outinen TK; Mantula P; Jaatinen P; Hämäläinen M; Moilanen E; Vaheri A; Huhtala H; Mäkelä S; Mustonen J
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31438470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.